Production (Stage)
D
PureTech Health plc PRTC
$18.20 -$0.80-4.21% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 334.15% 334.15% -67.07% -67.07% -84.88%
Total Depreciation and Amortization -6.14% -6.14% -40.74% -40.74% -59.30%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -809.13% -809.13% 48.99% 48.99% 79.08%
Change in Net Operating Assets -56.44% -56.44% -911.34% -911.34% 71.17%
Cash from Operations -33.28% -33.28% -22.85% -22.85% 55.45%
Capital Expenditure -- -- -- -- 100.00%
Sale of Property, Plant, and Equipment -75.64% -75.64% -68.14% -68.14% --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 191.18% 191.18% 26.28% 26.28% -5.37%
Cash from Investing 104.17% 104.17% 36.02% 36.02% -4.54%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -10.93% -10.93% 6.58% 6.58% 29.45%
Issuance of Common Stock -100.00% -100.00% -6.87% -6.87% -40.92%
Repurchase of Common Stock 91.02% 91.02% -1,363.00% -1,363.00% 44.32%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -31.88% -31.88% 100.00%
Cash from Financing 260.97% 260.97% -142.55% -142.55% 43.07%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 82.54% 82.54% -41.49% -41.49% 26.20%